Genzyme Builds New Manufacturing Facility As Takeover Deadline Approaches
This article was originally published in The Pink Sheet Daily
Executive Summary
Belgium-based plant will be used to manufacture Myozyme and Lumizyme for Pompe disease, a franchise that Genzyme says has the potential to become a blockbuster.